A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia-Reference-Cited by-同舟云学术

A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia

Published:2005-03 Issue:3 Volume:29 Page:263-271
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Bauer Kenneth S.,Karp Judith E.,Garimella Tushar S.,Wu Suhlan,Tan Ming,Ross Douglas D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia;Russo;Leuk. Lymphoma,2001

2. Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period;Baudard;Leukemia,1999

3. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B;Mayer;N Engl J Med,1994

4. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study;Leith;Blood,1997

5. Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients;Hartmann;Leuk. Lymphoma,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen;Aging;2020-04-07

2. Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives;International Journal of Molecular Sciences;2019-05-08

3. Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial;Journal of Hepatology;2018-06

4. Mode of Action Analyses of Neferine, a Bisbenzylisoquinoline Alkaloid of Lotus (Nelumbo nucifera) against Multidrug-Resistant Tumor Cells;Frontiers in Pharmacology;2017-05-05

5. Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins;Drug Resistance Updates;2017-05